When is dialysis indicated for patients with liver disease?

Dialysis Indications in Liver Disease

Dialysis should be initiated in patients with liver disease when they develop acute kidney injury (AKI) with specific clinical indications including worsening kidney function despite medical therapy, severe electrolyte disturbances (acidosis, hyperkalemia, hyponatremia), diuretic intolerance, or increasing volume overload—but only if the patient is a liver transplant candidate or has potentially reversible liver disease. 1

Clinical Decision Algorithm

Step 1: Determine Transplant Candidacy

• Transplant candidates: Dialysis is indicated as a bridge to liver transplantation 1
• Non-transplant candidates: Dialysis has extremely high mortality and should only be considered if:
  • The underlying liver lesion is potentially reversible (e.g., fulminant hepatic failure, extrahepatic biliary obstruction) 2
  • Other organ failures are reversible 1
  • A limited trial may be appropriate in highly selected cases 1

Step 2: Specific Clinical Triggers for Dialysis Initiation

Initiate renal replacement therapy (RRT) when any of the following occur 1:

• Progressive worsening of kidney function despite vasoconstrictor therapy (terlipressin/norepinephrine + albumin)
• Severe acidosis not responding to medical management
• Hyperkalemia refractory to treatment
• Severe hyponatremia unresponsive to therapy
• Diuretic intolerance
• Progressive volume overload despite maximal medical therapy

Step 3: Choose Dialysis Modality

For hemodynamically unstable patients (most with hepatorenal syndrome):

• Continuous RRT (CVVHD) is preferred over intermittent hemodialysis 1, 3
• Better tolerated in patients with tenuous hemodynamics 3

For stable outpatients with chronic kidney disease and cirrhosis:

• Hemodialysis is preferred over peritoneal dialysis 4
• Recent 2026 data shows peritoneal dialysis in cirrhosis patients has:
  • 23% higher mortality risk (HR 1.23)
  • 3.85-fold higher peritonitis risk
  • 51% higher sepsis risk
  • More hospitalizations 4

Critical Caveats and Pitfalls

The Cirrhosis Paradox

Patients with advanced cirrhosis have dismal outcomes with dialysis regardless of AKI etiology 1. Historical data shows zero survival in cirrhosis patients treated with dialysis 2, though this has improved modestly with modern techniques.

The MELD Score Problem

Successful treatment of AKI-HRS paradoxically lowers the MELD score (due to improved creatinine), disadvantaging transplant candidates despite no meaningful survival improvement 1. Some countries maintain pre-treatment MELD scores or assign extra points to address this issue.

Timing Considerations

• Pre-transplant dialysis shows comparable outcomes to transplant recipients without renal failure 5
• Post-transplant dialysis for prolonged periods has poor outcomes with ≤40% 3-year survival 5
• Dialysis may need to continue for up to 7 weeks before recovery in reversible cases 2

Contraindications to Dialysis

Do not initiate dialysis in 2, 6:

• Advanced irreversible cirrhosis without transplant candidacy
• Multiple irreversible organ failures
• Patients where dialysis may actually shorten prognosis

Complications to Monitor

Dialysis complications are most common in cirrhosis and fulminant hepatic failure 2:

• Intradialytic hypotension
• Gastrointestinal bleeding
• Intraperitoneal sepsis (with peritoneal dialysis)
• Cardiovascular events

Integration with Palliative Care

For critically ill cirrhosis patients with ACLF requiring dialysis or mechanical ventilation >48 hours, palliative care consultation should be considered to define prognosis and determine goals of care 7. This is not mutually exclusive with transplant listing 7.